| Tag | Content |
|---|
EnhancerAtlas ID | HS019-09098 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr2:46615690-46618090 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Crx | MA0467.1 | chr2:46616849-46616860 | AAGAGGATTAG | + | 6.62 | | HSF1 | MA0486.2 | chr2:46616519-46616532 | TTCTAGAAGCTTC | + | 6.28 | | MEF2A | MA0052.3 | chr2:46617816-46617828 | TTTATTTTTAGA | - | 6.07 | | MEF2C | MA0497.1 | chr2:46617815-46617830 | TTTTATTTTTAGAAT | - | 6.5 | | PLAG1 | MA0163.1 | chr2:46616943-46616957 | GAGGCCCTGGGGGG | + | 6.18 | | RARA(var.2) | MA0730.1 | chr2:46616351-46616368 | TGGCCTCTCTGTGACCT | - | 6.06 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_42141 | chr2:46614114-46617223 | Lung |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 46615901 | 46616102 | | chr2 | 46617133 | 46617274 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I046388 | chr2 | 46614836 | 46617666 |
|
Enhancer Sequence | ATGCCCATGT TCAGATGGGG GTGGAGAGTG AATGAACTGT TTTTTTTCTG GAGATCACGG 60
AAATGCAGAT TCATTTCTTT TACAACATGC AAGATTCAAC CACTTAACAT CCTTCCTCTC 120
CTGGATCCCG CACAAAAGAG ACTGCTTTTT TGTGAAAAAG AAACTTTTAC CAGGAGGCCT 180
GCAGAAGAAC AGTCAGGTTA ACCCGGCTCT TCCTTCCCTG AGGTAGTGGC CCTGGGTAAG 240
ACAGCACAGG ATGTTATCTC AGATGCTGAG AGGGGCTGAG AAACAATGTC GCCCAACCCC 300
ATCACTTCTT TTTTTCAACC TCCTCATTTT AGAGATGAGG AAACTGATGC CCAGGAAAAC 360
AAAGCGACTT GCCTACAGTC ACACAGGGAG TTAGTGGCAG GGTGGGGGCC AGAGCCCAGG 420
CCAGCATCAT GGGAACTGGG GCTGAACTCA CGTAAGTGAA AGGGCTGTGT TCTCTGCCCC 480
AGAGGTCACC GCTCACTGTC TCAGCCAGCA CTGGGCCTCC CACATGGCCC TTCCCAAATC 540
TTCCTTCCAG CCTCCTGCTC CTCACTTCCC TCCGGCACTC TCAGTTCTTC CAAAAATGAT 600
CCTGTCACCC CCATTTCTTC CAAACATTCC TCTGAGCTCA GCGACCCCTG TGGGAACTGC 660
TTGGCCTCTC TGTGACCTCA AATGAAGTCT AAATCAATTC TTTCACTACT AGACTGAACT 720
TTTCTTGGTC CCCCAGGACC CAGGAGAAAA GGATTTTGAA GTACTTCCCC AGCCCCACCT 780
AATACACAGT GTTTAAAAAT GATACTTCTT CGGCAATCAT GATCCTTCCT TCTAGAAGCT 840
TCCCAGCTAG TAGGGGAACC AAACAAAGCC CGCCTGGATG ACTGAGACCC TGTCTGAGAT 900
GGTGTGGGAT GATGGAGGCC CATGGCCCAG TTTTCCCAGC CAGTCCAAGC ATTAGATCAC 960
GTGCTTCCGC GTCCCCGCGG GTGCAGCTGT ACTTGGGCCA AGGGTCCCAT CGCGGGTTCA 1020
GAAAGCATGA TAACTATTGA TGCAAATGAG CCCTTGGTTG TTTTAGGGTG GACTTCAACT 1080
CCTGCAAATG TCCAGAGGAG GCCAGCAGAG ATCAGCCTGG GTCTTAGGAG TGAAGAATCT 1140
CCCACCAGAG CTGGGATGGA AGAGGATTAG ACAGGCAGCG GGAAAAGAGG TCATTCCAGG 1200
AGAAGTGGAC CAGGGAGACA AAGGCCTGAG GCCAGAATGA GCAATACATG CAAGAGGCCC 1260
TGGGGGGCAG GCAGGACGGG AGCTGGGAAG GAGGGGGCGG CCGGGCAGCC TGGCAACTCA 1320
CAACACAGAC CTAGAGTCAG ACGGACCTAG GTTCAAATCC CAGCCCTGCT GCTTCCTGCT 1380
GTGTAACCTC AAGGAAGCCC CTTAAACATC TGATAGCCTA AGTCTGCTGT TCTGTAGAAT 1440
GGTGGTGACA GCAGTCCCTA CCTCATAGGG TTTAAAGCTG GAGATACAAA TTTGGGTATG 1500
TGCAGTAGGT AAATTGTACT TAACTCCATG AGCTGGGATG AAATATGCCT CTGAGATAGA 1560
AGTGCAAAGA ACAGAGGTCG GGAGACAGAA CCTAGGCCAC TGGTAGAAGC CAGACTGAGC 1620
AGGAGCACCC AAGGAGCAGA AAGAAATCCA GGGGTATAGT ATCTCAAAAG CCAAGTGATA 1680
AGGGTGCTGC GGGAAGTAGG GCATAGTGAA CTGCATTACA CACACACTAG ACTGAAAGGT 1740
AAGGGAAGGG GAAAAAAATT GACTCGGATT TGCCAACATG GAGCTCACCA TCAACCTTAA 1800
CAAGAGCAGG TTTGGTGGGG AGCTAAGGAC AGCAGATTGG AGTAGACTGA GGAATGAGCT 1860
GGCTGGAGTG GGGAAACAGA GACCGTAGCA ATATACAACT CGTTTGGGAA GGTTCCCTGT 1920
GCAGGAAAGC AGGGAAATGG AGTGGAGCAA GAGGATGACA TGGGTCAGGG GAGTGTGTGG 1980
GAGTGTATAT GTGTGTGTGT GTGTATGTGT GTGTGTGTGT GGTTTCATAT TTAATCGACT 2040
TTTATCTTAG AATAGTTTTA GGTTTACAGA AAGGCTGTGA GACCATTATA AGAGTTCCCT 2100
GCACTCAGTT TCCTCTATTA TTTTATTTTA TTTTTAGAAT AGAGACGGGG TTTCCCTATG 2160
TTGCCCAGGC TGGTCTCAAA CTCGTGGGCT CAAGTGATCC TCCTGCCTCG GCCTCCCAAA 2220
GCGGTAGGAA TATAGACGTG AGCCACCGTG CCTGGCCTCC TCTATTGTTA ACATTACTAT 2280
GGTACATAAG TCACAATTAA TGAACCAGTA TTGGTACCTT ATTATCTAAA GCCTGTACTT 2340
TATTCCAGTT TTTAGTGTTA CTTAATATCT TTCTTTTTCT GTTCTAAGGT CCTATTCAGG 2400
|
